Human angiotensin II

Drug Profile

Human angiotensin II

Alternative Names: (Asp1-Ile5) angiotensin II; Angiotensin II (human); Delivert; TY 10721

Latest Information Update: 11 Apr 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Toa Eiyo
  • Developer Astellas Pharma; Toa Eiyo
  • Class Antineoplastics; Peptide fragments; Vasopressors
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Cancer

Most Recent Events

  • 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
  • 28 Nov 2000 Profile reviewed but no significant changes made
  • 17 Jul 1998 TY 10721 is now called human angiotensin II
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top